BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3469740)

  • 1. The correlation between acid suppression and peptic ulcer healing.
    Hunt RH; Howden CW; Jones DB; Burget DW; Kerr GD
    Scand J Gastroenterol Suppl; 1986; 125():22-31. PubMed ID: 3469740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
    Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
    Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between suppression of acidity and gastric ulcer healing rates.
    Howden CW; Hunt RH
    Aliment Pharmacol Ther; 1990 Feb; 4(1):25-33. PubMed ID: 2151756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate acid suppression in the treatment of acid-related conditions.
    Howden CW
    Pharmacol Ther; 1994; 63(1):123-34. PubMed ID: 7972343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
    Howden CW; Jones DB; Burget DW; Hunt RH
    Gut; 1986 Sep; 27(9):1058-61. PubMed ID: 3758819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing acid suppression for treatment of acid-related diseases.
    Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
    McIsaac RL; Dixon JS; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
    Mahachai V; Walker K; Pinchbeck B; Thomson AB
    Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates.
    Howden CW; Jones DB; Peace KE; Burget DW; Hunt RH
    Dig Dis Sci; 1988 May; 33(5):619-24. PubMed ID: 3282850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
    Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
    J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between inhibition of acid secretion and healing of peptic ulcers.
    Chiverton SG; Hunt RH
    Scand J Gastroenterol Suppl; 1989; 166():43-7; discussion 74-5. PubMed ID: 2690331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
    Naesdal J; Bodemar G; Walan A
    Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease.
    Howden CW; Burget DW; Hunt RH
    Scand J Gastroenterol Suppl; 1994; 201():79-82. PubMed ID: 8047830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.
    Tari A; Hamada M; Kamiyasu T; Fukino Y; Sumii M; Haruma K; Sumii K; Inoue M; Kajiyama G
    J Gastroenterol; 1996 Apr; 31(2):167-70. PubMed ID: 8680534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective drugs in the treatment of gastroduodenal ulcer disease.
    Koelz HR
    Scand J Gastroenterol Suppl; 1986; 125():156-64. PubMed ID: 3547612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer.
    Brummer RJ; Stockbrügger RW
    Dig Dis Sci; 1996 Oct; 41(10):2048-54. PubMed ID: 8888720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous omeprazole rapidly raises intragastric pH.
    Walt RP; Reynolds JR; Langman MJ; Smart HL; Kitchingman G; Somerville KW; Hawkey CJ
    Gut; 1985 Sep; 26(9):902-6. PubMed ID: 4029717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing.
    McCullough AJ; Graham DY; Knuff TE; Lanza FL; Levenson HL; Lyon DT; Munsell WP; Perozza J; Roufail WM; Sinar DR
    Gastroenterology; 1989 Oct; 97(4):860-6. PubMed ID: 2570730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.